A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer

被引：39
作者：
Anné, PR
Curran, WJ
机构：
[1] Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA USA
[2] Med Oncol Allegheny Gen Hosp, Pittsburgh, PA USA
来源：
SEMINARS IN RADIATION ONCOLOGY | 2002年 / 12卷 / 01期
关键词：
D O I：
10.1053/srao.2002.31358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：18 / 19
页数：2
相关论文
共 50 条
[31]   Radiation therapy in head and neck cancer [J].
Alfouzan, Afnan F. .
SAUDI MEDICAL JOURNAL, 2021, 42 (03) :247-254
[32]   Radiation therapy in head and neck cancer [J].
Tribius, S. ;
Petersen, C. ;
Knecht, R. ;
Ihloff, A. S. .
HNO, 2010, 58 (12) :1168-1173
[33]   Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial) [J].
Robijns, Jolien ;
Lodewijckx, Joy ;
Claes, Stefan ;
Van Bever, Leen ;
Pannekoeke, Luc ;
Censabella, Sandrine ;
Busse, Lore ;
Colson, Dora ;
Kaminski, Iris ;
Broux, Victoria ;
Puts, Sofie ;
Vanmechelen, Sofie ;
Timmermans, An ;
Noe, Leen ;
Bulens, Paul ;
Govers, Mieke ;
Maes, Annelies ;
Mebis, Jeroen .
RADIOTHERAPY AND ONCOLOGY, 2021, 158 :268-275
[34]   Impact of subcutaneous amifostine on xerostomia and survival during concurrent chemoradiation for head and neck cancer: 18-month follow-up data from a phase II trial. [J].
Law, A ;
Kennedy, T ;
Pellitteri, P ;
Wood, C ;
Wilkinson, M ;
Douglas, C ;
Yumen, O .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :518S-518S
[35]   Biodosimetry of head and neck cancer patients undergoing radiation therapy [J].
Kulshrestha, R. ;
Rathi, A. K. ;
Kapoor, S. ;
Singh, K. ;
Arora, S. ;
Polipalli, S. K. ;
Jindal, A. .
RADIOTHERAPY AND ONCOLOGY, 2018, 127 :S1267-S1268
[36]   Intensity modulated radiation therapy in patients with head and neck cancer [J].
Eagin, K. ;
Bas, H. ;
Guden, M. ;
Kucuk, N. ;
Cemile, C. ;
Egehan, I. ;
Kilic, A. .
RADIOTHERAPY AND ONCOLOGY, 2007, 82 :S61-S61
[37]   Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: Preliminary results from a randomized phase II clinical trial from Germany [J].
Bennett, CL ;
Lane, D ;
Stinson, T ;
Glatzel, M ;
Buntzel, J .
CANCER INVESTIGATION, 2001, 19 (02) :107-113
[38]   A phase II trial of docetaxel in squamous cell cancer of the head and neck [J].
Posner, M ;
Dreyfuss, A ;
Norris, C ;
Costello, R ;
Rossi, R ;
Poulin, M ;
Clark, J ;
Busse, P .
EUROPEAN JOURNAL OF CANCER, 1995, 31A :421-421
[39]   PHASE-II TRIAL OF MITOXANTRONE IN HEAD AND NECK-CANCER [J].
AAPRO, MS ;
ALBERTS, DS .
INVESTIGATIONAL NEW DRUGS, 1984, 2 (03) :329-330
[40]   p53 phase II trial for head and neck cancer [J].
不详 .
DRUG NEWS & PERSPECTIVES, 1997, 10 (08) :506-506
12345